Goldman doubles down on Nvidia as AI chip rivals gain ground — and 2026 crash talk returns

Goldman doubles down on Nvidia as AI chip rivals gain ground — and 2026 crash talk returns

New York, Jan 20, 2026, 08:26 EST

Goldman Sachs stuck with Nvidia and Broadcom as its top picks in AI computing on Tuesday, saying Nvidia’s lead remains strong despite custom silicon closing the cost gap. The bank noted that Google’s Broadcom-designed TPU is making rapid gains on “inference” economics—the process of running AI models post-training—but highlighted Nvidia’s CUDA software and faster rollout as crucial advantages in the growing GPU-versus-ASIC battle. (ASICs are specialized chips made for a single task.) 1

Nvidia investors face a turbulent period as the stock battles between being “still the backbone of AI” and concerns it’s “too big to run like it used to.” Shares slipped roughly 0.5% to $186.23 ahead of Tuesday’s U.S. market open.

Nvidia’s next key milestone is earnings. The company plans to release its fourth-quarter and full-year fiscal 2026 results on Feb. 25, per its investor relations calendar. 2

On Jan. 19, Motley Fool’s Will Healy labeled Nvidia a “buy now,” but cautioned the company’s massive scale might limit share-price jumps, even with strong growth. Healy noted Nvidia earns roughly 90% of its revenue from its data center segment. Analysts project about 63% revenue growth for fiscal 2026 and near 50% for 2027. He also highlighted a price-to-earnings ratio around 45. 3

On Tuesday, a separate Motley Fool article took a different tack, focusing on volatility. Keith Speights pointed out that Nvidia has suffered several 20%-plus “crashes” in recent years, warning that another steep drop in 2026 wouldn’t be shocking, even if it’s short-lived. He pegged Nvidia’s forward P/E (based on expected earnings) at 24.3 and highlighted CEO Jensen Huang’s comment that “the transition to agentic AI and physical AI … will be revolutionary.” 4

The bull case still hinges on demand. Nvidia’s latest quarterly report showed third-quarter revenue hitting $57.0 billion—up 62% year over year. The company projects fourth-quarter revenue around $65.0 billion, with a 2% margin of error. “Blackwell sales are off the charts, and cloud GPUs are sold out,” Huang said in the release. 5

The road ahead isn’t smooth. Should major cloud clients continue moving workloads to in-house chips, or if export controls and geopolitical tensions tighten once more, Nvidia might see growth slow or margins squeeze—just as investors wrestle with defining “normal” for a company of this scale.

The debate has fractured into two camps: banks such as Goldman zeroing in on AI infrastructure’s relative positioning, while traders prepare for rapid sell-offs like those Nvidia has conditioned the market to anticipate. The next key date to watch is Feb. 25.

Stock Market Today

Energy stocks set for a geopolitical week after Iran warning and oil rebound

Energy stocks set for a geopolitical week after Iran warning and oil rebound

7 February 2026
U.S. energy stocks rose Friday, with the S&P 500 energy sector up 1.88% and Exxon Mobil gaining 2.03%. Brent crude settled at $68.05 a barrel after Iran threatened U.S. bases if attacked. Saudi Aramco cut March Arab Light crude prices to a five-year low for Asia. Kazakhstan’s CPC Blend exports may drop 35% this month due to Tengiz oilfield disruptions.
Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

7 February 2026
U.S. financial stocks rose Friday, with the XLF fund up 1.8% and the Dow closing above 50,000 for the first time, gaining 2.47%. Goldman Sachs jumped 4.3%, JPMorgan 3.9%, and Citigroup 6.0%. The Federal Reserve held rates steady, and San Francisco Fed President Mary Daly signaled possible cuts this year. Investors await January jobs and inflation data next week.
ImmunityBio stock jumps before the open after FDA outlines next step for ANKTIVA filing
Previous Story

ImmunityBio stock jumps before the open after FDA outlines next step for ANKTIVA filing

CoreWeave stock jumps in premarket as AI infrastructure names rally — and a lawsuit looms
Next Story

CoreWeave stock jumps in premarket as AI infrastructure names rally — and a lawsuit looms

Go toTop